Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sarcoma, Soft-tissue”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06667544
What this trial is testing

RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation

Who this might be right for
KRAS G12D Mutation
Ranok Therapeutics (Hangzhou) Co., Ltd. 152
Testing effectiveness (Phase 2)Active Not RecruitingNCT05071209
What this trial is testing

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

Who this might be right for
Recurrent Alveolar RhabdomyosarcomaRecurrent Ewing SarcomaRecurrent Lymphoma+5 more
National Cancer Institute (NCI) 31
Testing effectiveness (Phase 2)Looking for participantsNCT07125183
What this trial is testing

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Who this might be right for
Sarcoma
University of Colorado, Denver 20
Testing effectiveness (Phase 2)Ended earlyNCT02575066
What this trial is testing

Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients

Who this might be right for
SarcomaSoft Tissue Sarcomas
The Netherlands Cancer Institute 25
Not applicableStudy completedNCT00026754
What this trial is testing

Eligibility Screening for the NIH Intramural Research Program Clinical Protocols

Who this might be right for
Breast CancerProstate CancerLung Cancer+2 more
National Cancer Institute (NCI) 19,522
Large-scale testing (Phase 3)Looking for participantsNCT06345729
What this trial is testing

Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 600
Testing effectiveness (Phase 2)Study completedNCT00515931
What this trial is testing

Radiation Therapy as Palliative Treatment of GIST

Who this might be right for
Sarcoma
Heikki Joensuu 25
Early research (Phase 1)UnknownNCT05487651
What this trial is testing

Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies

Who this might be right for
NHL, Relapsed, AdultB-cell LymphomaB-cell Leukemia+4 more
Athenex, Inc. 36
Early research (Phase 1)Looking for participantsNCT06957431
What this trial is testing

Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma

Who this might be right for
Advanced LeiomyosarcomaAdipocytic SarcomaAdvanced Liposarcoma
Washington University School of Medicine 18
Not applicableLooking for participantsNCT06243588
What this trial is testing

Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
Istituto Ortopedico Rizzoli 400
Testing effectiveness (Phase 2)Study completedNCT00006379
What this trial is testing

Non-Ablative Allo HSCT For Hematologic Malignancies or SAA

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Not applicableLooking for participantsNCT03818412
What this trial is testing

Circulating Tumor DNA in Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University Health Network, Toronto 40
Testing effectiveness (Phase 2)Study completedNCT01382030
What this trial is testing

Neoadjuvant and Adjuvant Chemotherapy in High-risk Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Heidelberg University 50
Testing effectiveness (Phase 2)Study completedNCT03320330
What this trial is testing

Pepinemab in Treating Younger Patients With Recurrent, Relapsed, or Refractory Solid Tumors

Who this might be right for
Recurrent Malignant Solid NeoplasmRecurrent OsteosarcomaRefractory Malignant Solid Neoplasm+1 more
Children's Oncology Group 26
Testing effectiveness (Phase 2)Study completedNCT02797977
What this trial is testing

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Who this might be right for
Advanced Solid Tumors
Sierra Oncology LLC - a GSK company 153
Testing effectiveness (Phase 2)Active Not RecruitingNCT04388839
What this trial is testing

Evolutionary Therapy for Rhabdomyosarcoma

Who this might be right for
Rhabdomyosarcoma
H. Lee Moffitt Cancer Center and Research Institute 12
Testing effectiveness (Phase 2)Study completedNCT00664781
What this trial is testing

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierBreast Cancer+1 more
Cancer Research UK 78
Early research (Phase 1)Study completedNCT04833582
What this trial is testing

Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma

Who this might be right for
Osteosarcoma
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 31
Testing effectiveness (Phase 2)Temporarily pausedNCT03316573
What this trial is testing

Pembrolizumab in Neoplasms or Lymphomas

Who this might be right for
LymphomaHistiocytic SarcomaFollicular Dendritic Cell Sarcoma+1 more
Dana-Farber Cancer Institute 18
Next Page